Beta-Blockers for the Prevention of Acute Exacerbations of COPD
Block-COPD
Sponsor: United States Department of Defense
Enrolling: Male and Female Patients
Study Length: 365 Days
Clinic Visits: 10
IRB Number: AAAQ9108
U.S. Govt. ID: NCT02587351
Contact: Sana Sajjad: 212-304-7969 / ss4901@cumc.columbia.edu
Additional Study Information: The objective of the Block-COPD Study is to determine if beta-blockers are safe and effective at reducing the number of exacerbations or flare-ups that people living with Chronic Obstructive Pulmonary Disease (COPD) experience. A beta-blockers is a drug that is taken by mouth and is currently used to treat a wide range of diseases including high blood pressure and heart disease. The purpose of this study is to determine if this drug can also help patients with COPD. We hope that this study will help us learn more about how to treat COPD.
This study is closed
Investigator
Keith Brenner, MD
Do You Qualify?
Have you ever been told by a doctor that you have chronic obstructive pulmonary disease (COPD) or emphysema Yes No
Have you had an exacerbation or a flare-up of your COPD symptoms within the last year Yes No
Submit
Cancel
You may be eligible for this study

Place Holder



Cancel
For more information, please contact:
Sana Sajjad
ss4901@cumc.columbia.edu
212-304-7969
This website uses cookies as well as similar tools and technologies to understand visitors’ experiences. By continuing to use this website, you consent to Columbia University’s usage of cookies and similar technologies, in accordance with the Columbia University Website Cookie Notice.
I AGREE